Physician profile
Robert W Smith
NPI 1598750739
$11,321.63
in general payments reported to CMS, 2019-2025
37 companies · $1,044 in 2025
The $1,044 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,274 · 2020: $2,892 · 2021: $1,285 · 2022: $1,955 · 2023: $1,112 · 2024: $1,761 · 2025: $1,044.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,916.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,916.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,290.57 | 2019-2020 | |
| Medtronic, INC. | $2,043.03 | 2021-2025 | Symplicity G3, Onyx Frontier, Avalus |
| Novartis Pharmaceuticals Corporation | $1,570.26 | 2019-2025 | |
| Amgen INC. | $643.53 | 2019-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $455.86 | 2019-2025 | Jardiance |
| Philips North America LLC | $439.55 | 2019-2024 | (Bq9) Coronary Ivus |
| E.R. Squibb & Sons, L.L.C. | $424.72 | 2019-2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $424.15 | 2019-2023 | Xarelto |
| Pfizer INC. | $351.54 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $342.59 | 2019-2023 | Farxiga |
| Shockwave Medical, INC | $317.71 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $293.56 | 2019-2024 | Avvigo Guidance System, Peripheral Rotalink Plus, Rotapro |
| Angiodynamics, INC. | $221.49 | 2020-2024 | Auryon Laser System 100-120 Vac |
| Amarin Pharma, INC. | $168.38 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $167.69 | 2019-2024 | Lifevest |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $153.66 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $120.97 | 2021-2024 | Verquvo |
| Cvrx, INC. | $107.08 | 2022 | |
| Impulse Dynamics (USA) INC. | $101.25 | 2022-2024 | Optimizer |
| Stryker Corporation | $88.94 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novo Nordisk INC | $73.63 | 2022-2025 | Rybelsus, Ozempic |
| Esperion Therapeutics, INC. | $64.24 | 2020-2025 | Nexletol |
| Biotronik INC. | $61.21 | 2019 | |
| Ethicon US, LLC | $54.56 | 2024 | Enseal, Echelon Flex, Ethicon |
| Cmp Pharma, INC. | $39.95 | 2021-2023 | Tadliq, Carospir, Norliqva |
| Bayer Healthcare Pharmaceuticals INC. | $35.86 | 2021 | |
| Cook Medical LLC | $32.75 | 2020 | |
| Cardiovascular Systems INC. | $31.18 | 2020-2021 | |
| Abiomed | $30.80 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $28.74 | 2020-2022 | |
| Arbor Pharmaceuticals, INC. | $23.99 | 2020-2021 | |
| Alnylam Pharmaceuticals INC. | $23.28 | 2023 | Onpattro |
| Kiniksa Pharmaceuticals International, Plc | $22.96 | 2024 | Arcalyst |
| Inspire Medical Systems, INC. | $20.82 | 2024 | Inspire |
| Actelion Pharmaceuticals US, INC. | $18.07 | 2024 | Opsumit, Uptravi |
| Tactile Systems Technology INC | $16.62 | 2023 | Flexitouch Plus, Entre Plus |
| Lundbeck LLC | $16.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.